FDA investigators audited the Fagron - Saint Paul, MN, United States facility and issued 6 inspectional observations (via FDA 483) on 11 Feb 2009.
Product details
- Category: Human Drugs
- Number of Observations: 6
- Inspection end: 11 Feb 2009
- Location: Saint Paul, United States
- FEI: 1000174332
